Angiogenesis during diabetic wound repair: from mechanism to therapy opportunity

Abstract

Diabetes mellitus, a pervasive chronic metabolic disorder, is often associated with complications such as impaired wound healing. Various factors, most notably vascular deficiency, govern the wound repair process in diabetic patients, significantly impeding diabetic wound healing; therefore, angiogenesis and its role in diabetic wound repair have emerged as important areas of research. This review aims to delve into the mechanisms of angiogenesis, the effects of diabetes on angiogenesis, and the association between angiogenesis and diabetic wound repair. This will ultimately offer valuable guidance regarding the ideal timing of diabetic wound treatment in a clinical setting.

Keywords

Angiogenesis / Diabetes mellitus / Diabetic foot ulcers / Timing of treatment / Diabetic wound

References

[1] Collaborators, GBDD.Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. Lancet 2023; 402: 203-34. https://doi.org/10.1016/S0140-6736(23)01301-6.

[2] Burgess JL, Wyant WA, Abdo Abujamra B, Kirsner RS, Jozic I. Diabetic Wound-Healing Science, Vol. 57. Medicina (Kaunas), 2021. https://doi.org/10.3390/medicina57101072.

[3] Armstrong, DG, Tan, TW, Boulton, AJM, Bus SA. Diabetic foot ulcers: a review. JAMA 2023; 330: 62-75. https://doi.org/10.1001/jama.2023.10578.

[4] Rodrigues, M, Kosaric, N, Bonham, CA, Gurtner GC. Wound healing: a cellular perspective. Physiol Rev 2019; 99: 665-706. https://doi.org/10.1152/physrev.00067.2017.

[5] Wang Z, Zhao F, Xu C, Zhang Q, Ren H, Huang X. et al. Metabolic reprogramming in skin wound healing. Burns Trauma 2024; 12: tkad047. https://doi.org/10.1093/burnst/tkad047.

[6] Chen CJ, Kajita H, Takaya K, Aramaki-Hattori N, Sakai S, Asou T. et al. Single-cell RNA-seq analysis reveals cellular functional heterogeneity in dermis between fibrotic and regenerative wound healing fates. Front Immunol 2022; 13: 875407. https://doi.org/10.3389/fimmu.2022.875407.

[7] Kolimi P, Narala S, Nyavanandi D, Youssef AAA, Dudhipala N. Innovative Treatment Strategies to Accelerate Wound Healing, Vol. 11. Trajectory and Recent Advancements. Cells, 2022. https://doi.org/10.3390/cells11152439.

[8] Akita S.Wound repair and regeneration: mechanisms, Signaling. Int J Mol Sci 2019; 20: 6328. https://doi.org/10.3390/ijms20246328.

[9] Morton, LM, Phillips TJ. Wound healing and treating wounds: differential diagnosis and evaluation of chronic wounds. J Am Acad Dermatol 2016; 74: 589-605. https://doi.org/10.1016/j.jaad.2015.08.068.

[10] Krzyszczyk, P, Schloss, R, Palmer, A, Berthiaume F. The role of macrophages in acute and chronic wound healing and interventions to promote pro-wound healing phenotypes. Front Physiol 2018; 9: 419. https://doi.org/10.3389/fphys.2018.00419.

[11] Lv D, Cao X, Zhong L, Dong Y, Xu Z, Rong Y. et al. Targeting phenylpyruvate restrains excessive NLRP3 inflammasome activation and pathological inflammation in diabetic wound healing. Cell Rep Med 2023; 4: 101129. https://doi.org/10.1016/j.xcrm.2023.101129.

[12] Zhang Y, Zhang YY, Pan ZW, Li QQ, Sun LH, Li X. et al. GDF11 promotes wound healing in diabetic mice via stimulating HIF-1a-VEGF/SDF-1a-mediated endothelial progenitor cell mobilization and neovascularization. Acta Pharmacol Sin 2023; 44: 999-1013. https://doi.org/10.1038/s41401-022-01013-2.

[13] Xiong Y, Chen L, Liu P, Yu T, Lin C, Yan C. et al. All-in-one: multifunctional hydrogel accelerates oxidative diabetic wound healing through timed-release of exosome and fibroblast growth factor. Small 2022; 18: e2104229. https://doi.org/10.1002/smll.202104229.

[14] Du H, Li S, Lu J, Tang L, Jiang X, He X. et al. Single-cell RNA-seq and bulk-seq identify RAB17 as a potential regulator of angiogenesis by human dermal microvascular endothelial cells in diabetic foot ulcers. Burns. Trauma 2023; 11: tkad020. https://doi.org/10.1093/burnst/tkad020.

[15] Okonkwo UA, Chen L, Ma D, Haywood VA, Barakat M, Urao N. et al. Compromised angiogenesis and vascular integrity in impaired diabetic wound healing. PLoS One 2020; 15: e0231962. https://doi.org/10.1371/journal.pone.0231962.

[16] Suh JW, Lee KM, Ko EA, Yoon DS, Park KH, Kim HS. et al. Promoting angiogenesis and diabetic wound healing through delivery of protein transduction domain-BMP2 formulated nanoparticles with hydrogel. J Tissue Eng 2023; 14: 20417314231190641. https://doi.org/10.1177/20417314231190641.

[17] Chen T, Song P, He M, Rui S, Duan X, Ma Y. et al. Sphingosine-1-phosphate derived from PRP-exos promotes angiogenesis in diabetic wound healing via the S1PR1/AKT/FN1 signalling pathway. Burns. Trauma 2023; 11: tkad003. https://doi.org/10.1093/burnst/tkad003.

[18] Yan Y, Wu R, Bo Y, Zhang M, Chen Y, Wang X. et al. Induced pluripotent stem cells-derived microvesicles accelerate deep second-degree burn wound healing in mice through miR-16-5p-mediated promotion of keratinocytes migration. Theranostics 2020; 10: 9970-83. https://doi.org/10.7150/thno.46639.

[19] Dvorak HF. Reconciling VEGF with VPF: the importance of increased vascular permeability for stroma formation in Tumors, healing wounds, and chronic inflammation. Front Cell Dev Biol 2021; 9: 660609. https://doi.org/10.3389/fcell.2021.660609.

[20] Shao, Z, Yin, T, Jiang, J, He, Y, Xiang, T, Zhou S. Wound microenvironment self-adaptive hydrogel with efficient angiogenesis for promoting diabetic wound healing. Bioact Mater 2023; 20: 561-73. https://doi.org/10.1016/j.bioactmat.2022.06.018.

[21] Xiong Y, Feng Q, Lu L, Qiu X, Knoedler S, Panayi AC. et al. Metal-organic frameworks and their composites for chronic wound healing: from bench to bedside. Adv Mater 2024; 36: e2302587. https://doi.org/10.1002/adma.202302587.

[22] Bus SA, Armstrong DG, Crews RT, Gooday C, Jarl G, Kirketerp-Moller K. et al. Guidelines on offloading foot ulcers in persons with diabetes (IWGDF 2023 update). Diabetes Metab Res Rev 2024; 40: e3647. https://doi.org/10.1002/dmrr.3647.

[23] Zhang JT, Wu MF, Ma MH, Zhao L, Zhu JY, Nian H. et al. Research on the wound healing effect of Shengji Huayu formula ethanol extract-derived fractions in streptozotocin-induced diabetic ulcer rats. BMC Complement Med Ther 2023; 23: 67. https://doi.org/10.1186/s12906-023-03894-0.

[24] Pulkkinen HH, Kiema M, Lappalainen JP, Toropainen A, Beter M, Tirronen A. et al. BMP6/TAZ-hippo signaling modulates angiogenesis and endothelial cell response to VEGF. Angiogenesis 2021; 24: 129-44. https://doi.org/10.1007/s10456-020-09748-4.

[25] Moreno, L, Popov, S, Jury, A, Al Sarraj, S, Jones, C, Zacharoulis S. Role of platelet derived growth factor receptor (PDGFR) overexpression and angiogenesis in ependymoma. J Neuro-Oncol 2013; 111: 169-76. https://doi.org/10.1007/s11060-012-0996-z.

[26] Zare, R, Abdolsamadi, H, Soleimani Asl, S, Radi, S, Bahrami, H, Jamshidi S.The bFGF can improve angiogenesis in oral mucosa and accelerate wound healing. Rep Biochem Mol Biol 2023; 11: 547-52. https://doi.org/10.52547/rbmb.11.4.547.

[27] Schonborn M, Gregorczyk-Maga I, Batko K, Bogucka K, Maga M, Plotek A. et al. Circulating Angiogenic factors and ischemic diabetic foot syndrome advancement-a pilot study. Biomedicines 2023; 11: 1559. https://doi.org/10.3390/biomedicines11061559.

[28] Zhao M, Wang S, Zuo A, Zhang J, Wen W, Jiang W. et al. HIF-1alpha/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury. Cell Mol Biol Lett 2021; 26: 40. https://doi.org/10.1186/s11658-021-00283-8.

[29] Ma Z, Mo R, Yang P, Ding Y, Zhang H, Dong Z. et al. PDK4 facilitates fibroblast functions and diabetic wound healing through regulation of HIF-1alpha protein stability and gene expression. FASEB J 2023; 37:e23215. https://doi.org/10.1096/fj.202300874RR.

[30] Chen L, Gao Y, Li Y, Wang C, Chen D, Gao Y. et al. Severe intermittent hypoxia modulates the macrophage phenotype and impairs wound healing through downregulation of HIF-2alpha. Nat Sci Sleep 2022;Volume 14: 1511-20. https://doi.org/10.2147/NSS.S382275.

[31] Zheng X, Narayanan S, Xu C, Eliasson Angelstig S, Grunler J, Zhao A. et al. Repression of hypoxia-inducible factor-1 contributes to increased mitochondrial reactive oxygen species production in diabetes. elife 2022; 11: 70714. https://doi.org/10.7554/eLife.70714.

[32] Dekoninck, S, Blanpain C. Stem cell dynamics, migration and plasticity during wound healing. Nat Cell Biol 2019; 21: 18-24. https://doi.org/10.1038/s41556-018-0237-6.

[33] Louiselle, AE, Niemiec, SM, Zgheib, C, Liechty KW. Macrophage polarization and diabetic wound healing. Transl Res 2021; 236: 109-16. https://doi.org/10.1016/j.trsl.2021.05.006.

[34] Audu CO, Melvin WJ, Joshi AD, Wolf SJ, Moon JY, Davis FM. et al. Macrophage-specific inhibition of the histone demethylase JMJD3 decreases STING and pathologic inflammation in diabetic wound repair. Cell Mol Immunol 2022; 19: 1251-62. https://doi.org/10.1038/s41423-022-00919-5.

[35] Geng K, Ma X, Jiang Z, Gu J, Huang W, Wang W. et al. WDR74 facilitates TGF-beta/Smad pathway activation to promote M2 macrophage polarization and diabetic foot ulcer wound healing in mice. Cell Biol Toxicol 2023; 39: 1577-91. https://doi.org/10.1007/s10565-022-09748-8.

[36] Kohler JB, Cervilha DAB, Riani Moreira A, Santana FR, Farias TM, Alonso Vale MIC. et al. Microenvironmental stimuli induce different macrophage polarizations in experimental models of emphysema. Biol Open 2019; 8. https://doi.org/10.1242/bio.040808.

[37] Zhang, W, Yang, X, Huang, X, Chen L. Bioinspired nanovesicles released from injectable hydrogels facilitate diabetic wound healing by regulating macrophage polarization and endothelial cell dysfunction. J Nanobiotechnology 2023; 21: 358. https://doi.org/10.1186/s12951-023-02119-3.

[38] Mei J, Zhou J, Kong L, Dai Y, Zhang X, Song W. et al. An injectable photo-cross-linking silk hydrogel system augments diabetic wound healing in orthopaedic surgery through spatiotemporal immunomodulation. J Nanobiotechnology 2022; 20: 232. https://doi.org/10.1186/s12951-022-01414-9.

[39] Zhou Z, Deng T, Tao M, Lin L, Sun L, Song X. et al. Snail-inspired AFG/GelMA hydrogel accelerates diabetic wound healing via inflammatory cytokines suppression and macrophage polarization. Biomaterials 2023; 299: 122141. https://doi.org/10.1016/j.biomaterials.2023.122141.

[40] Raffin, C, Vo, LT, Bluestone JA. T(reg) cell-based therapies: challenges and perspectives. Nat Rev Immunol 2020; 20: 158-72. https://doi.org/10.1038/s41577-019-0232-6.

[41] Yu J, Li H, Jia J, Huang Z, Liu S, Zheng Y. et al. Pandemic influenza a (H1N1) virus causes abortive infection of primary human T cells. Emerg Microbes Infect 2022; 11: 1191-204. https://doi.org/10.1080/22221751.2022.2056523.

[42] Yu Y, Chen Z, Wang Y, Li Y, Lu J, Cui L. et al. Infliximab modifies regulatory T cells and co-inhibitory receptor expression on circulating T cells in psoriasis. Int Immunopharmacol 2021; 96: 107722. https://doi.org/10.1016/j.intimp.2021.107722.

[43] Guo L, Zhu Z, Shi C, Jia Y, Nurzat Y, Su W. et al. Drug suspending during wound healing effectively weakens immunosuppression-related complications by preserving CD8(+) T cell function. Wound Repair Regen 2023; 31: 489-99. https://doi.org/10.1111/wrr.13086.

[44] Van Dis E, Fox DM, Morrison HM, Fines DM, Babirye JP, McCann LH. et al. IFN-gamma-independent control of M. Tuberculosis requires CD4 T cell-derived GM-CSF and activation of HIF-1alpha. PLoS Pathog 2022; 18: e1010721. https://doi.org/10.1371/journal.ppat.1010721.

[45] Aghajanian H, Kimura T, Rurik JG, Hancock AS, Leibowitz MS, Li L. et al. Targeting cardiac fibrosis with engineered T cells. Nature 2019; 573: 430-3. https://doi.org/10.1038/s41586-019-1546-z.

[46] Liu TT, Xu HH, Liu ZJ, Zhang HP, Zhou HT, Zhu ZX. et al. Downregulated calmodulin expression contributes to endothelial cell impairment in diabetes. Acta Pharmacol Sin 2023; 44: 2492-503. https://doi.org/10.1038/s41401-023-01127-1.

[47] Huang G, Cheng Z, Hildebrand A, Wang C, Cimini M, Roy R. et al. Diabetes impairs cardioprotective function of endothelial progenitor cell-derived extracellular vesicles via H3K9Ac inhibition. Theranostics 2022; 12: 4415-30. https://doi.org/10.7150/thno.70821.

[48] Wang, X, Wang, R, Jiang, L, Xu, Q, Guo X. Endothelial repair by stem and progenitor cells. J Mol Cell Cardiol 2022; 163: 133-46. https://doi.org/10.1016/j.yjmcc.2021.10.009.

[49] Hosseini, M, Shafiee A. Vascularization of cutaneous wounds by stem cells. Prog Mol Biol Transl Sci 2023; 199: 327-50. https://doi.org/10.1016/bs.pmbts.2023.03.002.

[50] Short WD, Steen E, Kaul A, Wang X, Olutoye OO 2nd, Vangapandu HV. et al. IL-10 promotes endothelial progenitor cell infiltration and wound healing via STAT3. FASEB J 2022; 36: e22298. https://doi.org/10.1096/fj.201901024RR.

[51] Chen, C, Lin, LY, Chen, JW, Chang TT. CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus. Cardiovasc Diabetol 2023; 22: 172. https://doi.org/10.1186/s12933-023-01900-w.

[52] Xu K, Deng S, Zhu Y, Yang W, Chen W, Huang L. et al. Platelet rich plasma loaded multifunctional hydrogel accelerates diabetic wound healing via regulating the continuously abnormal microenvironments. Adv Healthc Mater 2023; 12: e2301370. https://doi.org/10.1002/adhm.202301370.

[53] Bian X, Li B, Yang J, Ma K, Sun M, Zhang C. et al. Regenerative and protective effects of dMSC-sEVs on high-glucose-induced senescent fibroblasts by suppressing RAGE pathway and activating Smad pathway. Stem Cell Res Ther 2020; 11: 166. https://doi.org/10.1186/s13287-020-01681-z.

[54] Ariyanti AD, Zhang J, Marcelina O, Nugrahaningrum DA, Wang G, Kasim V. et al. Salidroside-Pretreated mesenchymal stem cells enhance diabetic wound healing by promoting paracrine function and survival of mesenchymal stem cells under Hyperglycemia. Stem Cells Transl Med 2019; 8: 404-14. https://doi.org/10.1002/sctm.18-0143.

[55] Knapp, M, Tu, X, Wu R. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacol Sin 2019; 40: 1-8. https://doi.org/10.1038/s41401-018-0042-6.

[56] Krisp, C, Jacobsen, F, McKay, MJ, Molloy, MP, Steinstraesser, L, Wolters DA. Proteome analysis reveals antiangiogenic environments in chronic wounds of diabetes mellitus type 2 patients. Proteomics 2013; 13: 2670-81. https://doi.org/10.1002/pmic.201200502.

[57] Zhang, J, Wu, Y, Zhang, J, Zhang, R, Wang, Y, Liu F. ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease. Metabolism 2023; 139: 155377. https://doi.org/10.1016/j.metabol.2022.155377.

[58] Xu H, Yang H, Wang Z, Tang Q, Cao X, Chen C. et al. Epidermal stem cell derived exosomes alleviate excessive autophagy induced endothelial cell apoptosis by delivering miR200b-3p to diabetic wounds. J Invest Dermatol 2023; 144: 1134-47.

[59] Xiong, W, Kong, X, Jiang, J, Yang, Z, Jiang R. Low androgen status inhibits erectile function by inducing eNOS uncoupling in rat corpus cavernosum. Andrology 2020; 8: 1875-83. https://doi.org/10.1111/andr.12844.

[60] Wan L, Bai X, Zhou Q, Chen C, Wang H, Liu T. et al. The advanced glycation end-products (AGEs)/ROS/NLRP3 inflammasome axis contributes to delayed diabetic corneal wound healing and nerve regeneration. Int J Biol Sci 2022; 18: 809-25. https://doi.org/10.7150/ijbs.63219.

[61] Soro-Paavonen A, Zhang WZ, Venardos K, Coughlan MT, Harris E, Tong DC. et al. Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. J Hypertens 2010; 28: 780-8. https://doi.org/10.1097/HJH.0b013e328335043e.

[62] Oh S, Son M, Park CH, Jang JT, Son KH, Byun K. The reducing effects of Pyrogallol-Phloroglucinol-6,6-Bieckol on high-fat diet-induced Pyroptosis in endothelial and vascular smooth muscle cells of mice aortas. Mar Drugs 2020; 18: 648. https://doi.org/10.3390/md18120648.

[63] Geng K, Ma X, Jiang Z, Huang W, Gu J, Wang P. et al. High glucose-induced STING activation inhibits diabetic wound healing through promoting M1 polarization of macrophages. Cell Death Discov 2023; 9: 136. https://doi.org/10.1038/s41420-023-01425-x.

[64] Kim E, Seo SH, Hwang Y, Ryu YC, Kim H, Lee KM. et al. Inhibiting the cytosolic function of CXXC5 accelerates diabetic wound healing by enhancing angiogenesis and skin repair. Exp Mol Med 2023; 55: 1770-82. https://doi.org/10.1038/s12276-023-01064-3.

[65] Yang, P, Li, S, Zhang, H, Ding, X, Tan Q. LRG1 accelerates wound healing in diabetic rats by promoting angiogenesis via the Wnt/beta-catenin Signaling pathway. Int J Low Extrem Wounds 2022; 2: 153473462210816. https://doi.org/10.1177/15347346221081610.

[66] Liu, Y, Zheng, B, Zheng, H, Xu, G, Jiang H. Resveratrol promotes diabetic wound healing by inhibiting notch pathway. J Surg Res 2024; 297: 63-70. https://doi.org/10.1016/j.jss.2024.02.004.

[67] Zheng X, Narayanan S, Sunkari VG, Eliasson S, Botusan IR, Grunler J. et al. Triggering of a Dll4-Notch1 loop impairs wound healing in diabetes. Proc Natl Acad Sci USA 2019; 116: 6985-94. https://doi.org/10.1073/pnas.1900351116.

[68] Lin, CJ, Lan, YM, Ou, MQ, Ji, LQ, Lin SD. Expression of miR-217 and HIF-1alpha/VEGF pathway in patients with diabetic foot ulcer and its effect on angiogenesis of diabetic foot ulcer rats. J Endocrinol Investig 2019; 42: 1307-17. https://doi.org/10.1007/s40618-019-01053-2.

[69] Guo, Y, Wang, Y, Liu, H, Jiang, X, Lei S. High glucose environment induces NEDD4 deficiency that impairs angiogenesis and diabetic wound healing. J Dermatol Sci 2023; 112: 148-57. https://doi.org/10.1016/j.jdermsci.2023.09.007.

[70] Carpino G, Cardinale V, Di Giamberardino A, Overi D, Donsante S, Colasanti T. et al. Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma. J Hepatol 2021; 75: 1377-86. https://doi.org/10.1016/j.jhep.2021.07.016.

[71] Qi W, Yang C, Dai Z, Che D, Feng J, Mao Y. et al. High levels of pigment epithelium-derived factor in diabetes impair wound healing through suppression of Wnt signaling. Diabetes 2015; 64: 1407-19. https://doi.org/10.2337/db14-1111.

[72] Yiu WH, Li Y, Lok SWY, Chan KW, Chan LYY, Leung JCK. et al. Protective role of kallistatin in renal fibrosis via modulation of Wnt/beta-catenin signaling. Clin Sci (Lond) 2021; 135: 429-46. https://doi.org/10.1042/CS20201161.

[73] Liang D, Lin WJ, Ren M, Qiu J, Yang C, Wang X. et al. M(6)a reader YTHDC1 modulates autophagy by targeting SQSTM1 in diabetic skin. Autophagy 2022; 18: 1318-37. https://doi.org/10.1080/15548627.2021.1974175.

[74] Catrina, SB, Zheng X. Hypoxia and hypoxia-inducible factors in diabetes and its complications. Diabetologia 2021; 64: 709-16. https://doi.org/10.1007/s00125-021-05380-z.

[75] Li G, Li D, Wu C, Li S, Chen F, Li P. et al. Homocysteine-targeting compounds as a new treatment strategy for diabetic wounds via inhibition of the histone methyltransferase SET7/9. Exp Mol Med 2022; 54: 988-98. https://doi.org/10.1038/s12276-022-00804-1.

[76] Holzer-Geissler JCJ, Schwingenschuh S, Zacharias M, Einsiedler J, Kainz S, Reisenegger P. et al. The impact of prolonged inflammation on wound healing. Biomedicines 2022; 10: 10. https://doi.org/10.3390/biomedicines10040856.

[77] Ge Y, Wang Q, Yao Y, Xin Q, Sun J, Chen W. et al. Framework nucleic acids-based VEGF Signaling activating system for angiogenesis: a dual stimulation strategy. Adv Sci (Weinh) 2024; 11: e2308701. https://doi.org/10.1002/advs.202308701.

[78] Tang L, Cai S, Lu X, Wu D, Zhang Y, Li X. et al. Platelet-derived growth factor Nanocapsules with Tunable controlled release for chronic wound healing. Small 2024; 20: e2310743. https://doi.org/10.1002/smll.202310743.

[79] Ko J, Jun H, Chung H, Yoon C, Kim T, Kwon M. et al. Comparison of EGF with VEGF non-viral gene therapy for cutaneous wound healing of streptozotocin diabetic mice. Diabetes Metab J 2011; 35: 226-35. https://doi.org/10.4093/dmj.2011.35.3.226.

[80] Lu W, Du X, Zou S, Fang Q, Wu M, Li H. et al. IFN-gamma enhances the therapeutic efficacy of MSCs-derived exosome via miR-126-3p in diabetic wound healing by targeting SPRED1. J Diabetes 2024; 16: e13465. https://doi.org/10.1111/1753-0407.13465.

[81] Narayanan S, Eliasson Angelstig S, Xu C, Grunler J, Zhao A, Zhu W. et al. HypoxamiR-210 accelerates wound healing in diabetic mice by improving cellular metabolism. Commun Biol 2020; 3: 768. https://doi.org/10.1038/s42003-020-01495-y.

[82] Abadir P, Hosseini S, Faghih M, Ansari A, Lay F, Smith B. et al. Topical reformulation of valsartan for treatment of chronic diabetic wounds. J Invest Dermatol 2018; 138: 434-43. https://doi.org/10.1016/j.jid.2017.09.030.

[83] Fox JD, Baquerizo-Nole KL, Macquhae F, Herskovitz I, Freedman JB, Vileikyte L. et al. Statins may be associated with six-week diabetic foot ulcer healing. Wound Repair Regen 2016; 24: 454-7. https://doi.org/10.1111/wrr.12400.

[84] Gunton, JE, Girgis, CM, Lau, T, Vicaretti, M, Begg, L, Flood V. Vitamin C improves healing of foot ulcers: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2021; 126: 1451-8. https://doi.org/10.1017/S0007114520003815.

[85] Yarahmadi A, Saeed Modaghegh MH, Mostafavi-Pour Z, Azarpira N, Mousavian A, Bonakdaran S. et al. The effect of platelet-rich plasma-fibrin glue dressing in combination with oral vitamin E and C for treatment of non-healing diabetic foot ulcers: a randomized, double-blind, parallel-group, clinical trial. Expert Opin Biol Ther 2021; 21: 687-96. https://doi.org/10.1080/14712598.2021.1897100.

[86] Li G, Ko CN, Li D, Yang C, Wang W, Yang GJ. et al. A small molecule HIF-1alpha stabilizer that accelerates diabetic wound healing. Nat Commun 2021; 12: 3363. https://doi.org/10.1038/s41467-021-23448-7.

[87] Soliman, AM, Teoh, SL, Ghafar, NA, Das S. Molecular concept of diabetic wound healing: effective role of herbal remedies. Mini Rev Med Chem 2019; 19: 381-94. https://doi.org/10.2174/1389557518666181025155204.

[88] Ma T, Zhao Y, Shen G, Chai B, Wang W, Li X. et al. Novel bilayer cell patch combining epidermal stem cells and angiogenic adipose stem cells for diabetic wound healing. J Control Release 2023; 359: 315-25. https://doi.org/10.1016/j.jconrel.2023.06.010.

[89] Kim, H, Wang, SY, Kwak, G, Yang, Y, Kwon, IC, Kim SH. Exosome-guided phenotypic switch of M1 to M2 macrophages for cutaneous wound healing. Adv Sci (Weinh) 2019; 6: 1900513. https://doi.org/10.1002/advs.201900513.

[90] Kerstan A, Dieter K, Niebergall-Roth E, Klingele S, Junger M, Hasslacher C. et al. Translational development of ABCB5(+) dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers. Stem Cell Res Ther 2022; 13: 455. https://doi.org/10.1186/s13287-022-03156-9.

[91] Kartika RW, Alwi I, Suyatna FD, Yunir E, Waspadji S, Immanuel S. et al. Wound healing in diabetic foot ulcer patients using combined use of platelet rich fibrin and hyaluronic acid, platelet rich fibrin and placebo: an open label. Randomized Controlled Trial Acta Med Indones 2021; 53: 268-75.

[92] Al-Jalodi, O, Kupcella, M, Breisinger, K, Serena TE. A multicenter clinical trial evaluating the durability of diabetic foot ulcer healing in ulcers treated with topical oxygen and standard of care versus standard of care alone 1 year post healing. Int Wound J 2022; 19: 1838-42. https://doi.org/10.1111/iwj.13789.

[93] Zhang J, Zhao B, Wei W, Wang D, Wang H, Zhang A. et al. Prospective, randomized, and controlled study of a human umbilical cord mesenchymal stem cell injection for treating diabetic foot ulcers. J Vis Exp 2023; 3: 65045. https://doi.org/10.3791/65045.

[94] Bonora BM, Cappellari R, Mazzucato M, Rigato M, Grasso M, Menegolo M. et al. Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: a phase IIa, randomized, double-blind, placebo-controlled trial. Stem Cells Transl Med 2020; 9: 965-73. https://doi.org/10.1002/sctm.20-0020.

[95] Miranda E, Bramono K, Yunir E, Reksodiputro MH, Suwarsa O, Rengganis I. et al. Efficacy of LL-37 cream in enhancing healing of diabetic foot ulcer: a randomized double-blind controlled trial. Arch Dermatol Res 2023; 315: 2623-33. https://doi.org/10.1007/s00403-023-02657-8.

[96] Gould LJ, Orgill DP, Armstrong DG, Galiano RD, Glat PM, Zelen CM. et al. Improved healing of chronic diabetic foot wounds in a prospective randomised controlled multi-Centre clinical trial with a microvascular tissue allograft. Int Wound J 2022; 19: 811-25. https://doi.org/10.1111/iwj.13679.

[97] Hajhosseini B, Chiou GJ, Virk SS, Chandra V, Moshrefi S, Meyer S. et al. Hyperbaric oxygen therapy in Management of Diabetic Foot Ulcers: Indocyanine green angiography may Be used as a biomarker to analyze perfusion and predict response to treatment. Plast Reconstr Surg 2021; 147: 209-14. https://doi.org/10.1097/PRS.0000000000007482.

[98] Carstens MH, Quintana FJ, Calderwood ST, Sevilla JP, Rios AB, Rivera CM. et al. Treatment of chronic diabetic foot ulcers with adipose-derived stromal vascular fraction cell injections: safety and evidence of efficacy at 1 year. Stem Cells Transl Med 2021; 10: 1138-47. https://doi.org/10.1002/sctm.20-0497.

[99] Armstrong DG, Orgill DP, Galiano R, Glat PM, Carter M, Zelen CM. et al. Complete wound closure following a single topical application of a novel autologous homologous skin construct: first evaluation in an open-label, single-arm feasibility study in diabetic foot ulcers. Int Wound J 2020; 17: 1366-75. https://doi.org/10.1111/iwj.13404.

[100] Cao T, Ji P, Zhang Z, Xiao D, Wang KJ, Li N. et al. A prospective randomized controlled study of antibiotic bone cement in the treatment of diabetic foot ulcer. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi 2023; 39: 311-8. https://doi.org/10.3760/cma.j.cn501225-20221111-00485.